输尿管皮肤造口患者尿路感染危险因素及风险评估研究进展

谢雨晴; 王俊; 吉学碧; 王萍; 王海峰; 李旭敏; 黄麟雅

doi:10.12259/j.issn.2095-610X.S20231124

输尿管皮肤造口患者尿路感染危险因素及风险评估研究进展

doi: 10.12259/j.issn.2095-610X.S20231124

昆明医科大学第二附属医院泌尿外科，云南昆明　650101

基金项目: 国家自然科学基金资助项目（82260609）；昆明医科大学第二附属医院院内基金资助项目（ynIIT2022013）

详细信息

作者简介:
谢雨晴（1998～），女，云南保山人，在读硕士研究生，护士，主要从事临床护理的工作

通讯作者:
王俊，E-mail：ynwangjun@163.com

中图分类号: R473.73
计量
- 文章访问数: 1655
- HTML全文浏览量: 906
- PDF下载量: 20
- 被引次数: 0
出版历程
- 收稿日期: 2023-06-08
- 网络出版日期: 2023-11-09
- 刊出日期: 2023-11-30

Research Progress on Risk Factors and Risk Assessment of Urinary Tract Infection in Patients with Ureterostomy

Dept. of Urology，The 2nd Affiliated Hospital of Kunming Medical University，Yunnan Institute of Urology，Kunming Yunnan 650101，China

摘要

摘要: 对输尿管皮肤造口患者尿路感染（UTI）的诊断标准、流行病学概况、危害、发生机制、危险因素、风险评估和针对性护理作一综述，指出潜在危险因素、构建和推广科学可行的输尿管皮肤造口患者尿路感染的早期风险预警评分十分必要。旨在为开展我国输尿管皮肤造口患者尿路感染危险因素的相关研究、预警模型的研制、临床决策的制定和实施提供参考。
- 膀胱癌 /
- 输尿管皮肤造口 /
- 尿路感染 /
- 风险评估 /
- 危险因素 /
- 护理
Abstract: This paper reviews the diagnostic criteria, epidemiology, hazards, mechanisms, risk factors, risk assessment and targeted care of urinary tract infection （UTI） in patients with ureteral dermatostomy. The paper proposes the necessity of constructing and promoting a scientific and feasible early risk warning score for urinary tract infection in patients with ureteral dermatostomy for these potential risk factors. The aim is to provide a reference for the study of risk factors of urinary tract infection in ureteral cutaneous stomy patients, the development of an early warning model, and the formulation and implementation of clinical decision-making.
- Bladder cancer /
- Ureterostomy /
- Urinary tract infection /
- Risk assessment /
- Risk factors /
- Nursing

HTML全文

参考文献(35)

[1]	李辉章,郑荣寿,杜灵彬,等. 中国膀胱癌流行现状与趋势分析[J]. 中华肿瘤杂志,2021,43(3):293-298.
[2]	Richters A,Aben K K H,Kiemeney L A L M. The global burden of urinary bladder cancer:An update[J]. World J Urol,2020,38(8):1895-1904. doi: 10.1007/s00345-019-02984-4
[3]	Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. doi: 10.3322/caac.21660
[4]	Witjes J A,Bruins H M,Cathomas R,et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer:Summary of the 2020 guidelines[J]. Eur Urol,2021,79(1):82-104. doi: 10.1016/j.eururo.2020.03.055
[5]	黄蓉,曹英汤利萍,等. 输尿管皮肤造口病人尿路感染病原菌分布及影响因素分析[J]. 护理研究,2022,36(11):2007-2012. doi: 10.12102/j.issn.1009-6493.2022.11.023
[6]	Lu X,Jiang H,Wang D,et al. Early wrning models to predict the 90-day urinary tract tnfection risk after radical cystectomy and urinary diversion for patients with bladder cancer[J]. Front Surg,2022,8:782029-782037. doi: 10.3389/fsurg.2021.782029
[7]	Thergaonkar R W,Hari P. Current management of urinary tract infection and vesicoureteral reflux[J]. Indian J Pediatr,2020,87(8):625-632. doi: 10.1007/s12098-019-03099-9
[8]	Kuy S,Gupta R,Roy C,et al. Incidence of catheter-associated urinary tract infections with compliance with preventive guidelines[J]. JAMA Surg,2020,155(7):661-662. doi: 10.1001/jamasurg.2020.0428
[9]	Soriano A,Hassani D,Harvie H,et al. Incidence of and risk factors for postoperative urinary tract infection after abdominal and vaginal colpopexy[J]. Female Pelvic Med Reconstr Surg,2021,27(1):e75-e81. doi: 10.1097/SPV.0000000000000814
[10]	Souhail B,Charlot P,Deroudilhe G,et al. Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis[J]. Eur J Clin Microbiol Infect Dis,2020,39(11):2077-2083. doi: 10.1007/s10096-020-03953-1
[11]	Gayarre Abril P,Subirá Ríos J,Muñiz Suárez L,et al. Urinary tract infection as the main cause of admission in cystectomized patients. La infección del tracto urinario como causa principal de ingreso en pacientes cistectomizados[J]. Actas Urol Esp (Engl Ed),2021,45(4):247-256. doi: 10.1016/j.acuro.2020.10.001
[12]	Kranz J,Schmidt S,Wagenlehner F,et al. Catheter-associated urinary tract infections in adult patients[J]. Dtsch Arztebl Int,2020,117(6):83-88.
[13]	刘敏,吴路遥. 留置尿管相关性尿路感染的易感因素及预防护理研究[J]. 实用临床医药杂志,2018,22(8):121-124.
[14]	Yuan Q,Huang R,Tang L,et al. Screening biomarkers and constructing a predictive model for symptomatic urinary tract infection and asymptomatic bacteriuria in patients undergoing cutaneous ureterostomy: A metagenomic next-generation sequencing study[J]. Dis Markers,2022,2022:7056517-7056523.
[15]	张萌,吴文霞,蒋龙元. 根治性膀胱全切除并输尿管皮肤造口术后尿路感染病原菌及药敏分析[J]. 岭南急诊医学杂志,2018,23(5):457-459. doi: 10.3969/j.issn.1671-301X.2018.05.019
[16]	王双凤,刘会范,左书强,等. 输尿管皮肤造口患者尿路感染的危险因素分析及预防对策[J]. 中国消毒学杂志,2018,35(11):853-855. doi: 10.11726/j.issn.1001-7658.2018.11.017
[17]	Luzum M,Sebolt J,Chopra V. Catheter-associated urinary tract infection,clostridioides difficile colitis,central line-associated bloodstream infection,and methicillin-resistant staphylococcus aureus[J]. Med Clin North Am,2020,104(4):663-679. doi: 10.1016/j.mcna.2020.02.004
[18]	郭薇,孙凤军,邱学文,等. 尿路感染及其治疗药物的研究进展[J]. 中国药房,2017,28(17):2441-2444. doi: 10.6039/j.issn.1001-0408.2017.17.38
[19]	O'Brien W J,Gupta K,Itani K M F. Association of postoperative infection with risk of long-term infection and mortality[J]. JAMA Surg,2020,155(1):61-68. doi: 10.1001/jamasurg.2019.4539
[20]	徐彬,王子源,刘春. 输尿管支架管相关尿路感染及抗菌生物材料的研究进展[J]. 临床泌尿外科杂志,2021,36(5):406-411. doi: 10.13201/j.issn.1001-1420.2021.05.016
[21]	Neugent M L,Hulyalkar N V,Nguyen V H,et al. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection[J]. mBio,2020,11(2):e00218-220.
[22]	Flores-Mireles A,Hreha T N,Hunstad D A. Pathophysiology,treatment,and prevention of catheter-associated urinary tract infection[J]. Top Spinal Cord Inj Rehabil,2019,25(3):228-240. doi: 10.1310/sci2503-228
[23]	Parker W P,Toussi A,Tollefson M K,et al. Risk factors and microbial distribution of urinary tract infections following radical cystectomy[J]. Urology,2016,94(8):96-101.
[24]	Magistro G,Zimmermann L,Bischoff R,et al. The natural course of urinalysis after urinary diversion[J]. World J Urol,2021,39(5):1559-1567. doi: 10.1007/s00345-020-03355-0
[25]	Hirobe M,Tanaka T,Shindo T,et al. Complications within 90 days after radical cystectomy for bladder cancer: Results of a multicenter prospective study in Japan[J]. Int J Clin Oncol,2018,23(4):734-741. doi: 10.1007/s10147-018-1245-z
[26]	Ghoreifi A,Van Horn C M,Xu W,et al. Urinary tract infections following radical cystectomy with enhanced recovery protocol:A prospective study[J]. Urol Oncol,2020,38(3):75.e9-75. doi: 10.1016/j.urolonc.2019.12.021
[27]	Kohada Y,Goriki A,Yukihiro K,et al. The risk factors of urinary tract infection after transurethral resection of bladder tumors[J]. World J Urol,2019,37(12):2715-2719. doi: 10.1007/s00345-019-02737-3
[28]	Li F,Song M,Xu L,et al. Risk factors for catheter-associated urinary tract infection among hospitalized patients: A systematic review and meta-analysis of observational studies[J]. J Adv Nurs,2019,75(3):517-527. doi: 10.1111/jan.13863
[29]	艾米如拉江·艾尔肯,刘强,等. 根治性膀胱切除术后发生尿路感染的危险因素[J]. 现代泌尿外科杂志,2022,27(6):489-493. doi: 10.3969/j.issn.1009-8291.2022.06.009
[30]	倪利萍,王薇,何屹,等. 输尿管皮肤造口患者尿路感染相关因素指标体系构建[J]. 护士进修杂志,2018,33(24):2228-2231,2251. doi: 10.16821/j.cnki.hsjx.2018.24.006
[31]	Catto J W F,Khetrapal P,Ricciardi F,et al. Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer:A randomized clinical trial[J]. JAMA,2022,327(21):2092-2103. doi: 10.1001/jama.2022.7393
[32]	Cacciamani G E,Medina L,Lin-Brande M,et al. Timing,patterns and predictors of 90-day readmission rate after robotic radical cystectomy[J]. J Urol,2021,205(2):491-499. doi: 10.1097/JU.0000000000001387
[33]	Aldhaam N A,Hussein A A,Elsayed A S,et al. Detailed analysis of urinary tract infections after robot-assisted radical cystectomy[J]. J Endourol,2021,35(1):62-70. doi: 10.1089/end.2020.0316
[34]	Chuang L,Tambyah P A. Catheter-associated urinary tract infection[J]. J Infect Chemother,2021,27(10):1400-1406. doi: 10.1016/j.jiac.2021.07.022
[35]	McCormick J Z,Cardwell S M,Wheelock C,et al. Impact of ambulatory antimicrobial stewardship on prescribing patterns for urinary tract infections[J]. J Clin Pharm Ther,2020,45(6):1312-1319. doi: 10.1111/jcpt.13210

相关文章(20)

[1]	饶梅子, 蒋心怡, 缪佳蓉. 溃疡性结肠炎合并EB病毒和巨细胞病毒感染的危险因素分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241113
[2]	刘怡涵, 刘俊, 金永梅, 田波, 白劲松. HIV抗病毒治疗患者心血管疾病风险评估及危险因素分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241022
[3]	孟丽燕, 王超群, 陈星慧, 何军晶, 牛雅茹, 马丽莎. 早期宫颈癌术后HPV持续感染的危险因素分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240422
[4]	王双双, 李亚玲, 陈丽琴, 韩永慧, 麻明彪, 李小娟. 儿童重症监护病区CRE感染的危险因素及耐药情况分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230918
[5]	丁煜昊, 王剑刃, 谢涛, 林荔青, 林泽西, 朱巍巍, 傅西安, 蒲军. 后交通动脉瘤破裂风险因素分析与评估, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221210
[6]	陈珮琪, 杨宗璐, 赵玲, 杜士刚, 杨璐, 李诗雨, 戴雨如, 柯亭羽. 不同评估方法在T2DM 心血管病风险评估中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220406
[7]	熊世锋, 邹浩. 胆囊癌淋巴结转移的危险因素分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220318
[8]	张桂梅, 陈蜀, 宋云华, 吴阳, 周虹媛. AECOPD患者再入院危险因素分析及预测模型的构建, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220830
[9]	沈居丽, 贾惠芳, 郜玫, 段金梅, 刘萍, 孙祖燕, 林惠仙. 基于风险评估的集束化护理在预防全子宫切除术后下肢深静脉血栓中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220212
[10]	陈珮琪, 杨宗璐, 赵玲, 杜士刚, 杨璐, 李诗雨, 戴雨如, 柯亭羽. 甲状腺功能在T2DM 10 a心血管病风险评估中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211215
[11]	刘佳, 和茵, 刘鑫. 肿瘤患者PICC导管相关性感染的危险因素及护理对策, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210116
[12]	李丹娜, 王俊, 杨明莹, 余力锐, 李娜, 杨毅娇. 膀胱癌根治性切除输尿管皮肤造口术尿路造口患者术后生命质量影响因素, 昆明医科大学学报.
[13]	李丹娜, 杨明莹, 王俊, 王留芳, 吴光柳, 王会笑, 陈奖国, 姚呈, 黄应龙. 膀胱全切原位尿流改道术患者生命质量下降的术前危险因素, 昆明医科大学学报.
[14]	雷玉英, 高洁, 王饶祥, 钏莉雪, 郝金钢. 弥散加权成像在膀胱癌诊断的价值, 昆明医科大学学报.
[15]	黄振华, 石鑫, 王辉涛, 张劲松, 王光, 郝金刚, 刘建和. 磁共振弥散加权成像在膀胱癌T分期的应用价值, 昆明医科大学学报.
[16]	刘漪. 呼吸重症监护病房多重耐药鲍曼不动杆菌感染危险因素回顾性分析, 昆明医科大学学报.
[17]	朱靖. 越南籍跨境女性性工作者性病艾滋病感染的潜在危险因素分析, 昆明医科大学学报.
[18]	谭向来. 以RIFLE标准评估住院患者急性肾损伤发病率、预后及相关危险因素, 昆明医科大学学报.
[19]	. 膀胱全切回肠代膀胱术后并发下肢静脉血栓2例护理体会, 昆明医科大学学报.
[20]	. 肌层浸润性膀胱癌的治疗策略, 昆明医科大学学报.